Mandibular advancement therapy does not reduce inflammatory and metabolic biomarkers in patients with severe OSA: a randomized controlled trial

W. Trzepizur (Angers, France), S. Recoquillon (Angers, France), J. Pépin (Grenoble, France), B. Vielle (Angers, France), V. Bironneau (Poitiers, France), F. Chouet-Girard (Le Mans, France), S. Launois (Paris, France), N. Meslier (Angers, France), J. Meurice (Poitiers, France), X. Nguyen (Paris, France), A. Paris (Le Mans, France), P. Priou (Angers, France), R. Tamisier (Grenoble, France), F. Goupil (Le Mans, France), B. Fleury (Paris, France), F. Gagnadoux (Angers, France)

Source: International Congress 2018 – Upper airways morphology and diagnostics, and the challenges associated with mandibular advancement
Disease area: Sleep and breathing disorders

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Trzepizur (Angers, France), S. Recoquillon (Angers, France), J. Pépin (Grenoble, France), B. Vielle (Angers, France), V. Bironneau (Poitiers, France), F. Chouet-Girard (Le Mans, France), S. Launois (Paris, France), N. Meslier (Angers, France), J. Meurice (Poitiers, France), X. Nguyen (Paris, France), A. Paris (Le Mans, France), P. Priou (Angers, France), R. Tamisier (Grenoble, France), F. Goupil (Le Mans, France), B. Fleury (Paris, France), F. Gagnadoux (Angers, France). Mandibular advancement therapy does not reduce inflammatory and metabolic biomarkers in patients with severe OSA: a randomized controlled trial. 5372

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Targeting treatable traits in severe asthma: a randomised controlled trial
Source: Eur Respir J, 55 (3) 1901509; 10.1183/13993003.01509-2019
Year: 2020



The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial
Source: Eur Respir J, 54 (2) 1900518; 10.1183/13993003.00518-2019
Year: 2019



Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial
Source: Eur Respir J, 54 (5) 1802134; 10.1183/13993003.02134-2018
Year: 2019



Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial
Source: ERJ Open Res, 5 (3) 00110-2019; 10.1183/23120541.00110-2019
Year: 2019



Evidence generation for the clinical impact of myCOPD in patients with mild, moderate and newly diagnosed COPD: a randomised controlled trial
Source: ERJ Open Res, 6 (4) 00460-2020; 10.1183/23120541.00460-2020
Year: 2020



Do marker states improve measurement properties of utility instruments: a randomized multi-center trial in patients with chronic respiratory disease
Source: Eur Respir J 2004; 24: Suppl. 48, 295s
Year: 2004

Factors affecting patients’ decision to adjust treatment; secondary analysis of a randomised trial of treatment optimisation in patients with severe asthma
Source: Virtual Congress 2021 – Asthma burden and management I
Year: 2021


Using placebo-controlled trials to define predictors of future exacerbations in severe asthma patients
Source: Eur Respir J, 58 (6) 2101702; 10.1183/13993003.01702-2021
Year: 2021



Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial
Source: Virtual Congress 2021 – ALERT: COPD
Year: 2021



Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial
Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019
Year: 2020



Acupuncture improves nutritional status and BODE index in patients with chronic obstructive pulmonary disease: A randomized, placebo-controlled trial
Source: Annual Congress 2011 - COPD management
Year: 2011


Economic arguments in favor of immediate management of patients with moderate-to-severe obstructive sleep apnea syndrome. A randomised controlled trial
Source: Eur Respir J 2003; 22: Suppl. 45, 353s
Year: 2003

A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma
Source: Eur Respir J, 51 (1) 1701126; 10.1183/13993003.01126-2017
Year: 2018



AVAPS-AE vs. ST mode: A randomised controlled trial in patients with obesity hypoventilation syndrome
Source: International Congress 2018 – New insights in the management of chronic respiratory failure
Year: 2018



A randomised, double-blind, crossover, placebo-controlled trial of a mandibular advancement device for the treatment of snoring and mild obstructive sleep apnoea-hypopnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 102s
Year: 2002

Tele-assistance in chronic respiratory failure patients: a randomised clinical trial
Source: Annual Congress 2008 - Integrated care and long-term strategies
Year: 2008


Long-term efficacy of a home-based airway clearance programme to improve cough severity in patients with bronchiectasis:a randomised controlled trial>
Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections
Year: 2019




A prospective randomised double-blind placebo controlled trial of venlafaxine in patients with stable chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 32s
Year: 2006

CPAP impact on memory processes in OSA patients, a randomized sham controlled trial
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016

Telemetrically triggered interventions in the first month of cpap treatment - A prospective, randomized controlled intervention trial in patients with a new diagnosis of obstructive sleep apnea syndrome
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016